43. Short Report: Pathophysiology Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

F. K. Knop, Diabet Med. 2013 Oct;30(10):1214-8

Aim: Resveratrol, a natural polyphenolic compound produced by various plants (e.g. red grapes) and found in red wine, has glucose-lowering effects in humans and rodent models of obesity and/or diabetes. The mechanisms behind these effects have been suggested to include resveratrol-induced secretion of the gut incretin hormone glucagon-like peptide-1. We investigated postprandial incretin hormone and glucagon responses in obese human subjects before and after 30 days of resveratrol supplementation.

Method: Postprandial plasma responses of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide and glucagon were evaluated in 10 obese men [subjects characteristics (mean _ standard error of the mean): age 52 _ 2 years; BMI 32 _ 1 kg/m2, fasting plasma glucose 5.5 _ 0.1 mmol/l] who had been given a dietary supplement of resveratrol (Resvida_ 150 mg/day) or placebo for 30 days in a randomized, double-blind, crossover design with a 4-week washout period. At the end of each intervention period a standardized meal test (without co-administration of resveratrol) was performed.

Result: Resveratrol supplementation had no impact on fasting plasma concentrations or postprandial plasma responses (area under curve values) of glucose-dependent insulinotropic polypeptide (11.2 _ 2.1 vs. 11.8 _ 2.2 pmol/l, P = 0.87; 17.0 _ 2.2 vs. 14.8 _ 1.6 min 9 nmol/l, P = 0.20) or glucagon-like peptide-1 (15.4 _ 1.0 vs. 15.2 _ 0.9 pmol/l, P = 0.84; 5.6 _ 0.4 vs. 5.7 _ 0.3 min 9 nmol/l, P = 0.73). Resveratrol supplementation significantly suppressed postprandial glucagon responses (4.4 _ 0.4 vs. 3.9 _ 0.4 min 9 nmol/l, P = 0.01) without affecting fasting glucagon levels (15.2 _ 2.2 vs. 14.5 _ 1.5 pmol/l, P = 0.56). Conclusion: Our data suggest that 30 days of resveratrol supplementation does not affect fasting or postprandial incretin hormone plasma levels in obese humans, but suppresses postprandial glucagon responses.

One Reply to “43. Short Report: Pathophysiology Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects”

  1. I would like to consider the opportunity of thanking you for your professional instruction I have constantly enjoyed viewing your site. I am looking forward to the particular commencement of my school research and the entire groundwork would never have been complete without surfing your web site. If I can be of any assistance to others, I might be delighted to help as a result of what I have gained from here.

Leave a Reply

Your email address will not be published. Required fields are marked *